Skip to main content

Table 3 Distribution of types of recommendation, by implementation group

From: Which factors affect the implementation of geriatric recommendations by primary care physicians?

 

Q1- Implementation 0–24% (N = 124)

Q2- Implementation 25–49% (N = 103)

Q3- Implementation 50–74% (N = 143)

Q4- Implementation 75–100% (N = 118)

All (N = 488)

P*

P **

 

Mean ± SD

Range

N

Mean ± SD

Range

N

Mean ± SD

Range

N

Mean ± SD

Range

N

Mean ± SD

Range

N

Add/increase dose of drug

2.0 ± 1.0

1–5

97

1.9 ± 1.0

1–5

87

2.1 ± 1.2

1–5

111

1.9 ± 1.1

1–5

94

2.0 ± 1.1

1–5

389

0.65

0.44

Stop/decrease dose of drug

2.3 ± 1.5

1–7

74

2.1 ± 1.3

1–7

58

2.3 ± 1.5

1–7

90

2.0 ± 1.4

1–6

68

2.2 ± 1.5

1–7

290

0.86

0.98

All pharmacologic recommendations

3.3 ± 1.8

1–9

110

2.9 ± 1.75

1–9

96

3.2 ± 2.1

1–10

137

3.2 ± 1.9

1–9

103

3.2 ± 1.9

1–10

446

0.63

0.76

Laboratory tests

2.1 ± 1.2

1–6

52

1.7 ± 1.1

1–7

53

2.3 ± 1.3

1–5

62

2.0 ± 1.2

1–7

63

2.0 ± 1.2

1–7

230

0.08

0.78

Imaging and other diagnostic tests

1.4 ± 0.6

1–4

73

1.4 ± 0.7

1–4

61

1.5 ± 0.8

1–5

71

1.6 ± 0.7

1–3

50

1.5 ± 0.7

1–5

255

0.61

0.15

“MD” referral

1.5 ± 0.7

1–1

56

1.5 ± 0.6

1–3

63

1.6 ± 0.9

1–4

63

1.4 ± 0.7

1–3

45

1.5 ± 0.7

1–4

207

0.44

0.52

“Non-MD” referral

1.4 ± 0.6

1–1

90

1.4 ± 0.5

1–2

64

1.3 ± 0.5

1–3

90

1.3 ± 0.5

1–3

71

1.4 ± 0.5

1–4

315

0.53

0.42

Immunization

1.9 ± 0.8

1–3

62

1.9 ± 0.8

1–3

60

1.8 ± 0.8

1–3

77

1.4 ± 0.5

1–3

53

1.8 ± 0.8

1–3

252

0.019

0.002

Total

7.2 ± 3.5

1–17

124

7.1 ± 3.3

3–18

103

7.3 ± 3.7

2–18

143

6.5 ± 3.6

1–15

118

7.0 ± 3.6

1–18

488

0.27

0.11

  1. P* among all Q groups, P** between Q1/Q4